govt.fyi
Back to SB 1677
Texas Legislature· SB 1677Effective on 9/1/25

Relating to a study on prevention and reduction of diabetes-related amputation, the official text

Shown verbatim: the complete text as captured from the official page posted by the Texas Legislature, fetched 2026-08-29. Where this bill amends existing law, language marked for deletion in the official page appears here in brackets. This is the enrolled version. The official bill page.
S.B. No. 1677

AN ACT

relating to a study on prevention and reduction of diabetes-related

amputation.

BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:

SECTION 1. (a) In this Act:

(1) "Department" means the Department of State Health

Services.

(2) "Institution of higher education" has the meaning

assigned by Section 61.003, Education Code.

(b) The Texas Higher Education Coordinating Board shall

designate an institution of higher education to conduct a study on

the prevention and reduction of diabetes-related amputation, using

existing institutional resources. The institution must have a

Research Activity Designation: Research 1: Very High Research

Spending and Doctorate Production under the 2025 Carnegie

Classification of Institutions of Higher Education.

(c) In conducting the study, the institution of higher

education designated under Subsection (b) of this section shall:

(1) collaborate with the department;

(2) identify and examine information on amputations

resulting from diabetes; and

(3) develop recommendations regarding:

(A) amputation prevention related to diabetic

foot ulcers and peripheral artery disease;

(B) methods for increasing public awareness of

diabetes-related amputation;

(C) best practices for reducing the number of

amputations performed; and

(D) policy solutions for ensuring access to

treatments to assist with preventing amputation, including:

(i) insurance coverage for therapies

designed to treat diabetic foot ulcers, including topical oxygen

therapy;

(ii) timely and equitable access to

evidence-supported medical tools, technologies, and services to

assist with the prevention of avoidable amputations;

(iii) methods to improve and incentivize

quality care to avoid amputations when possible; and

(iv) methods to promote collaboration and

cooperation among interested persons.

(d) In conducting the study, the institution of higher

education designated under Subsection (b) of this section shall

consult with the following individuals:

(1) the commissioner of state health services;

(2) a physician licensed in this state who specializes

in endocrinology;

(3) a nurse licensed in this state with expertise in

diabetes education;

(4) a vascular surgeon with expertise in amputation

prevention;

(5) a physician, physician assistant, or advanced

practice registered nurse with expertise in amputation prevention;

(6) a podiatrist with expertise in treating diabetic

foot ulcers;

(7) a podiatrist or vascular surgeon affiliated with

the United States Department of Veterans Affairs;

(8) a representative of a public health provider;

(9) at least three individuals diagnosed with diabetes

or who have experienced diabetes-related amputation;

(10) a representative of the American Diabetes

Association; and

(11) other individuals as the institution determines

necessary.

(e) Not later than September 1, 2026, the institution of

higher education designated under Subsection (b) of this section

shall prepare and submit to the department a report summarizing the

results of the study and containing recommendations for legislative

or other action. The department shall post the report on the

department's Internet website. The post must include:

(1) the information on which the institution's

determinations and recommendations are based; and

(2) the methodologies the institution used to conduct

the study.

SECTION 2. This Act expires September 1, 2027.

SECTION 3. This Act takes effect September 1, 2025.

______________________________
______________________________

President of the Senate
Speaker of the House

I hereby certify that S.B. No. 1677 passed the Senate on

April 10, 2025, by the following vote: Yeas 24, Nays 6.

______________________________

Secretary of the Senate

I hereby certify that S.B. No. 1677 passed the House on

May 24, 2025, by the following vote: Yeas 78, Nays 57, three

present not voting.

______________________________

Chief Clerk of the House

Approved:

______________________________

Date

______________________________

Governor
Every fact on this page links to its source, starting with the official bill record.